Mumbai, India , is rapidly emerging as a significant hub for the manufacture of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established robust manufacturing facilities focusing on this important antiviral drug . Identifying the precise top manufacturers can be difficult due to fluctuating market dynamics, but reputable names often